SCHEMBL18113923

SCHEMBL18113923

COc1ncnc(OC)c1C(=O)Nc1nc(C(F)(F)F)c(C2COC(C)(C)O2)s1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18113870 0.82 TRPV4 (0.33) —
SCHEMBL18113769 0.81 TRPV4 (0.38) —
SCHEMBL20481600 0.81 NPC1 (0.39) —
SCHEMBL18113828 0.80 NPC1 (0.35) —
SCHEMBL20481492 0.80 PIK3CG (0.34) —
SCHEMBL18113907 0.79 IRAK4 (0.36) —
SCHEMBL18113891 0.79 ALDH1A1 (0.30) —
SCHEMBL18113787 0.78 KDM4E (0.32) —
SCHEMBL18113837 0.78 RIPK1 (0.33) —
SCHEMBL18113860 0.78 RIPK1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180243298-A1 TRPV3 MODULATORS ABBVIE INC. 2018-08-30 — — US claimed
WO-2016160938-A1 N-(1,3-THIAZOL-2-YL)PYRIMIDINE-5-CARBOXAMIDES AS TRPV3 MODULATORS ABBVIE INC. (US) 2016-10-06 — — WO claimed
US-20180243298-A1 TRPV3 MODULATORS ABBVIE INC. 2018-08-30 — — US disclosed
WO-2016160938-A1 N-(1,3-THIAZOL-2-YL)PYRIMIDINE-5-CARBOXAMIDES AS TRPV3 MODULATORS ABBVIE INC. (US) 2016-10-06 — — WO disclosed
Send feedback